Seeking Alpha

NuVasive (NUVA +4.5%) pops on a Baird upgrade to outperfrom. Baird cites its proprietary survey...

NuVasive (NUVA +4.5%) pops on a Baird upgrade to outperfrom. Baird cites its proprietary survey of spine/neurosurgeons suggesting spine market dynamics are somewhat flat, but the industry's conversion to lateral lumbar fusion creates an opportunity for NuVasive to gain market share.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector